NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Effects of anticoagulants on human plasma soluble corin levels measured by ELISA.

Author(s): Dong N, Dong J, Liu P, Xu L, Shi S, Wu Q

Publication: Clin Chim Acta, 2010, Vol. 411, Page 1998-2003

PubMed ID: 20800586 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of anticoagulant, gender, age, and storage conditions on the measurement of corin in plasma and serum specimens.

Conclusion of Paper

Use of sodium citrate or EDTA as anticoagulants resulted in significantly lower plasma corin levels when compared to levels measured in either serum or heparin-plasma, which were similar to each other. Corin levels in EDTA-plasma were higher in males than in females, but age had no significant effect. In EDTA-plasma, native corin was stable for 24 hours at room temperature while recombinant corin was stable for 48 hours. Stability increased when specimens were stored at 4 degrees C. The addition of protease inhibitors had no effects on the stability of corin. Further, no effect of up to 3 freeze-thaw cycles on corin stability was found in sodium citrate-plasma, EDTA-plasma or serum, but levels of corin significantly decreased in heparin-plasma after 2 freeze-thaw cycles.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of anticoagulant, gender, and age on the measurement of native corin in plasma and serum specimens.

    Summary of Findings:

    Use of sodium citrate or K2EDTA as anticoagulants resulted in significantly lower plasma corin levels when compared to levels measured in either serum or heparin-plasma, which were similar to each other. Corin levels were higher in males than in females when measured in K2EDTA-plasma (p<0.001). There were no significant differences found in K2EDTA-plasma corin levels based on age.

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Protein ELISA
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Aliquots and Components Blood and blood products Plasma
    Serum
    Preaquisition Patient gender Female
    Male
    Preaquisition Patient age 16-30 y
    31-45 y
    46-60 y
    >60 y
    Biospecimen Acquisition Anticoagulant Heparin
    Potassium EDTA
    Sodium citrate
    None
  2. Study Purpose

    The purpose of this study was to determine the effects of storage temperature and duration, freeze-thaw cycling, and the addition of protease inhibitors on the stability of native and recombinant corin in plasma and serum specimens.

    Summary of Findings:

    After 24 hours at room temperature, corin levels in K2EDTA-plasma significantly decreased. However, at 4 degrees C, corin levels in K2EDTA-plasma remained stable for 72 hours. Recombinant human corin added to K2EDTA-plasma specimens exhibited stability similar to native corin at 4 degrees C, however, recombinant corin was stable at room temperature up to 48 hours. The addition of protease inhibitor cocktail did not affect native or recombinant corin stability at either temperature. Up to 3 freeze-thaw cycles had no effects on the stability of native corin in K2EDTA-plasma, sodium citrate-plasma, or serum. However, after 2 freeze-thaw cycles, corin levels significantly decreased in heparin-plasma (p<0.05).

    Biospecimens
    Preservative Types
    • None (Fresh)
    • Frozen
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Protein ELISA
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Storage Storage temperature Room temperature
    4 degrees C
    Storage Storage duration 0 h
    4 h
    8 h
    12 h
    24 h
    48 h
    72 h
    Storage Freeze/thaw cycling 0 cycles
    1 cycle
    2 cycles
    3 cycles
    Analyte Extraction and Purification Protease inhibitor Cocktail
    No protease inhibitor added
    ELISA Specific Targeted peptide/protein Native corin
    Recombinant corin
    Biospecimen Aliquots and Components Blood and blood products Plasma
    Serum
    Biospecimen Preservation Type of fixation/preservation Frozen
    None (fresh)
    Biospecimen Acquisition Anticoagulant Sodium citrate
    Potassium EDTA
    Heparin

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...